Latest news about KMS Medisurgi
KMS Medisurgi
132.80
0.00(0.00%)
Company Performance:
View Company Insights1D0.00%
1M0.00%
6M0.00%
1Y0.00%
5Y0.00%
More news about KMS Medisurgi
15Apr 26
KMS Medisurgi Limited Submits SEBI Compliance Certificate for Q4FY26
KMS Medisurgi Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) with BSE Limited on 14.04.2026. The certificate, prepared by registrar KFIN Technologies Limited, confirms that all company shares remain in dematerialised form with no re-materialisation requests received during the quarter ended 31st March, 2026, demonstrating continued regulatory compliance.
14Jan 26
KMS Medisurgi Limited Exempted from Corporate Governance Reporting Requirements Due to SME Listing Status
KMS Medisurgi Limited has notified BSE that it is exempt from corporate governance reporting under Regulation 27(2) for Q3FY26 due to its SME platform listing status. The exemption under SEBI LODR Regulation 15(2) covers multiple corporate governance provisions for SME-listed companies. Managing Director Siddharth Kanakia communicated this exemption status to BSE on 13th January 2026.
14Nov 25
KMS Medisurgi Reports Rs 29.63 Lacs Profit in Half-Year Results
KMS Medisurgi Limited, listed on BSE SME, announced financial results for the half-year ended September 30. The company reported a profit after tax of Rs 23.15 lacs, with revenue from operations at Rs 661.66 lacs. Total income stood at Rs 666.13 lacs, while total expenses were Rs 636.51 lacs. The balance sheet shows total assets of Rs 1,216.35 lacs and shareholders' funds of Rs 831.73 lacs. Auditors raised concerns about employee benefit accounting and inventory valuation methods. Management acknowledged these issues and is working on addressing them.
05Sept 25
KMS Medisurgi Sets 27th AGM Date, Recommends Rs 0.05 Per Share Dividend
KMS Medisurgi Limited has scheduled its 27th Annual General Meeting for September 30, 2025. The Board has recommended a final dividend of Rs 0.05 per equity share for FY 2024-25. The Record Date for dividend eligibility is set for September 23, 2025, with book closure from September 24-30, 2025. Key agenda items include financial statement adoption, dividend declaration, director re-appointment, and appointment of Secretarial Auditors. E-voting services will be available for shareholders from September 27-29, 2025.
Industry Peers
Poly Medicure
Q-Line Biotech
Tarsons Products
Laxmi Dental
Hemant Surgical Industries
Vasa Denticity
Osel Devices
Fabtech Technologies
Prevest Denpro
Nureca
1,738.50
(-0.53%)
726.20
(+1.57%)
311.20
(-2.03%)
202.84
(+0.14%)
470.00
(+1.85%)
390.00
(0.0%)
372.15
(+0.13%)
147.02
(-0.27%)
407.60
(+4.29%)
332.75
(-3.14%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
